We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Boot Barn and Cardinal health both posted strong results, also raising guidance.
Both stocks sport a favorable Zacks Rank.
Both companies are seeing improved margins and strong sales growth.
The 2025 Q4 earnings season is rapidly flying by, with all Magnificent 7 members already delivering their results outside of beloved NVIDIA. The period has so far been positive, with growth remaining strong and a solid number of companies exceeding quarterly expectations.
Concerning some winners of the cycle so far, Boot Barn (BOOT - Free Report) and Cardinal Health (CAH - Free Report) both raised guidance in one way or another, with each also seeing favorable post-earnings reactions.
Boot Barn Sees Strong Margin Performance
Boot Barn posted strong results in its release, with sales climbing 16% year-over-year alongside a 5.7% charge higher in same store sales. The same store sales growth is particularly notable, telling us that its existing stores are seeing strong performance while it also continues to open new locations.
Below is a chart illustrating Boot Barn’s sales on a quarterly basis, with the recent $705.6 million print reflecting a quarterly record.
Image Source: Zacks Investment Research
Concerning store openings, the company opened 25 new locations throughout the periods, bringing its overall tally up to 514 at quarter end. BOOT also enjoyed an improved profitability picture, with its gross margin growing to 39.9% vs. a 39.3% print in the same period last year. Consumer-focused stocks, particularly retail, are often highly sensitive to margin performance, helping explain the strong post-earnings reaction and guide higher.
BOOT’s margins picture has remained positive for several periods now, seeing nice expansion off 2023 lows. Please note that the chart below is on a trailing twelve-month basis.
Image Source: Zacks Investment Research
Boot Barn now expects to open 70 new stores in its FY26, with sales also expected to reach a band of $2.24 - $2.25 billion. Same store sales growth is forecasted to be in a range of 6.5% - 7.5%, continuing its recent streak of momentum nicely.
And to top it off, the stock sports the highly-coveted Zacks Rank #1 (Strong Buy), with EPS expectations notably bullish for the above-mentioned FY26.
Image Source: Zacks Investment Research
Cardinal Health Sees Broad Strength
Cardinal Health posted a double-beat relative to our consensus expectations, with sales soaring 18.8% from the year-ago period alongside a sizable 36.3% year-over-year growth rate in adjusted EPS.
Cardinal Health’s sales have seen great growth over recent periods after some stagnation throughout 2024, as shown below in the chart that illustrates CAH’s sales on a quarterly basis.
Image Source: Zacks Investment Research
Strength was primarily broad-based across its segments, with sales in Pharmaceuticals and Specialty Solutions climbing 19% year-over-year. Its Global Medical Products and Distribution saw its sales grow 3% YoY, whereas its ‘Other’ segment (includes at-home solutions, OptiFreight Logistics, and Nuclear and Precision Health Solutions) saw a strong 34% year-over-year climb. It’s worth noting that its Pharmaceuticals and Specialty Solutions accounts for the vast majority of its sales, contributing roughly 90%.
Similar to BOOT above, Cardinal Health has seen its margins recover nicely over recent periods, as shown below. Please note that the chart tracks margins on a trailing twelve-month basis.
Image Source: Zacks Investment Research
Cardinal Health raised its FY26 outlook following the strong quarter, now expecting adjusted EPS in a band of $10.15 - $10.35, with the midpoint suggesting 24.5% year-over-year growth. The updated outlook is reflected in positive earnings estimate revisions, as shown below. The stock sports a favorable Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Putting Everything Together
Guidance upgrades are a common sign of near-term outperformance, particularly when a favorable Zacks Rank is involved. Both stocks above – Boot Barn (BOOT - Free Report) and Cardinal Health (CAH - Free Report) – have experienced just that, posting robust quarterly results and enjoying positive post-earnings earnings estimate revisions in addition to their strong post-earnings reactions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Earnings Winners: 2 Buy Rated Stocks Raising Guidance
Key Takeaways
The 2025 Q4 earnings season is rapidly flying by, with all Magnificent 7 members already delivering their results outside of beloved NVIDIA. The period has so far been positive, with growth remaining strong and a solid number of companies exceeding quarterly expectations.
Concerning some winners of the cycle so far, Boot Barn (BOOT - Free Report) and Cardinal Health (CAH - Free Report) both raised guidance in one way or another, with each also seeing favorable post-earnings reactions.
Boot Barn Sees Strong Margin Performance
Boot Barn posted strong results in its release, with sales climbing 16% year-over-year alongside a 5.7% charge higher in same store sales. The same store sales growth is particularly notable, telling us that its existing stores are seeing strong performance while it also continues to open new locations.
Below is a chart illustrating Boot Barn’s sales on a quarterly basis, with the recent $705.6 million print reflecting a quarterly record.
Image Source: Zacks Investment Research
Concerning store openings, the company opened 25 new locations throughout the periods, bringing its overall tally up to 514 at quarter end. BOOT also enjoyed an improved profitability picture, with its gross margin growing to 39.9% vs. a 39.3% print in the same period last year. Consumer-focused stocks, particularly retail, are often highly sensitive to margin performance, helping explain the strong post-earnings reaction and guide higher.
BOOT’s margins picture has remained positive for several periods now, seeing nice expansion off 2023 lows. Please note that the chart below is on a trailing twelve-month basis.
Image Source: Zacks Investment Research
Boot Barn now expects to open 70 new stores in its FY26, with sales also expected to reach a band of $2.24 - $2.25 billion. Same store sales growth is forecasted to be in a range of 6.5% - 7.5%, continuing its recent streak of momentum nicely.
And to top it off, the stock sports the highly-coveted Zacks Rank #1 (Strong Buy), with EPS expectations notably bullish for the above-mentioned FY26.
Image Source: Zacks Investment Research
Cardinal Health Sees Broad Strength
Cardinal Health posted a double-beat relative to our consensus expectations, with sales soaring 18.8% from the year-ago period alongside a sizable 36.3% year-over-year growth rate in adjusted EPS.
Cardinal Health’s sales have seen great growth over recent periods after some stagnation throughout 2024, as shown below in the chart that illustrates CAH’s sales on a quarterly basis.
Image Source: Zacks Investment Research
Strength was primarily broad-based across its segments, with sales in Pharmaceuticals and Specialty Solutions climbing 19% year-over-year. Its Global Medical Products and Distribution saw its sales grow 3% YoY, whereas its ‘Other’ segment (includes at-home solutions, OptiFreight Logistics, and Nuclear and Precision Health Solutions) saw a strong 34% year-over-year climb. It’s worth noting that its Pharmaceuticals and Specialty Solutions accounts for the vast majority of its sales, contributing roughly 90%.
Similar to BOOT above, Cardinal Health has seen its margins recover nicely over recent periods, as shown below. Please note that the chart tracks margins on a trailing twelve-month basis.
Image Source: Zacks Investment Research
Cardinal Health raised its FY26 outlook following the strong quarter, now expecting adjusted EPS in a band of $10.15 - $10.35, with the midpoint suggesting 24.5% year-over-year growth. The updated outlook is reflected in positive earnings estimate revisions, as shown below. The stock sports a favorable Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Putting Everything Together
Guidance upgrades are a common sign of near-term outperformance, particularly when a favorable Zacks Rank is involved. Both stocks above – Boot Barn (BOOT - Free Report) and Cardinal Health (CAH - Free Report) – have experienced just that, posting robust quarterly results and enjoying positive post-earnings earnings estimate revisions in addition to their strong post-earnings reactions.